Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasis
Authors:
- 1 May 2014
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 35 (5) , 227-236
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AR 06394, DK 057501)
This publication has 153 references indexed in Scilit:
- Mutations in the TGF-β repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysmNature Genetics, 2012
- Osteocyte Signaling in BoneCurrent Osteoporosis Reports, 2012
- Identification of a central role for complement in osteoarthritisNature Medicine, 2011
- Role of Endothelial-Mesenchymal Transition (EndoMT) in the Pathogenesis of Fibrotic DisordersThe American Journal of Pathology, 2011
- Age-dependent alteration of TGF-β signalling in osteoarthritisCell and tissue research, 2011
- Extracellular microfibrils: contextual platforms for TGFβ and BMP signalingCurrent Opinion in Cell Biology, 2009
- TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formationNature Medicine, 2009
- Endocytosis of the Type III Transforming Growth Factor-β (TGF-β) Receptor through the Clathrin-independent/Lipid Raft Pathway Regulates TGF-β Signaling and Receptor Down-regulationJournal of Biological Chemistry, 2008
- OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelinesOsteoarthritis and Cartilage, 2008
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part IIArthritis & Rheumatism, 2007